1 uals were adults who had received 2 doses of mumps vaccine.

2 of 18 and 24 years had received two doses of mumps vaccine.

3 uence variations in mixed virus cultures and mumps vaccines.

4 ntly in all chicken cell-derived measles and mumps vaccines.

5 ing of virus seeds used in the production of mumps vaccines.

6       The widespread use of a second dose of mumps vaccine among U.S. schoolchildren beginning in 199

7 icating that it is a promising candidate for mumps vaccine development.

8 esponses in human serum samples from the pre-mumps vaccine era.

9  United States heightened concerns regarding mumps vaccine failure.

10 investigated the origin of RT in measles and mumps vaccines from a U.S. manufacturer and confirm the

11      The persistence of cellular immunity to mumps vaccine has not been defined.

12 ted mumps viruses used in the manufacture of mumps vaccines have neurovirulent properties, a monkey n

13 f RT activity in all RT-positive measles and mumps vaccines may not be similar and depend on the part

14                             A more effective mumps vaccine or changes in vaccine policy may be needed

15                                              Mumps vaccines prepared from the Jeryl Lynn strain typic

16 euroattenuation and neurovirulence, ensuring mumps vaccine safety has proven problematic, as demonstr

17 nt studies of chick cell-derived measles and mumps vaccines show evidence of two types of retrovirus

18 ) activity in chick cell-derived measles and mumps vaccines showed this activity to be associated wit

19  induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralized the outbrea

20 6, 9, or 12 months to respond to measles and mumps vaccines was evaluated by measuring T cell prolife